Tyrosols and derivatives
Search Within Results
1
–
2
of
2
results
1
Medchemexpress LLC VX-702 50mg | 745833-23-2 | 50MG
VX-702 is a highly selective inhibitor of p38 MAPK 14-fold higher potency against the p38 versus p38 [1
2
Medchemexpress LLC VX-702 | 745833-23-2 | 99.7% | 404.32 | 25 MG
VX-702 is a highly selective inhibitor of p38α MAPK, demonstrating 14-fold higher potency against p38α compared to p38β. It is intended for research use only and not for patient use.
- Highly selective p38α MAPK inhibitor, exhibiting 14-fold higher potency against p38α than p38β.
- Inhibits p38 activation in platelets at 1 μM concentration.
- No effect on platelet aggregation induced by p38 MAPK agonists.
- Inhibits cytokine production of IL-6, IL-1β, and TNFα.
- Long half-life of 16 to 20 hours in vivo.
- Predominantly cleared renally.
- Comparable efficacy to methotrexate and prednisolone in inhibiting wrist joint erosion and inflammation.